Prasad Sharmila S, Keely Simon, Talley Nicholas J, Kairuz Therése, Walker Marjorie M
Faculty of Health and Medicine, School of Biomedical Science and Pharmacy, University of Newcastle, Callaghan, New South Wales 2308, Australia.
Priority Research Centre, Digestive Health and Neurogastroenterology, University of Newcastle, New Lambton Heights, New South Wales 2308, Australia.
Pharmacy (Basel). 2020 Apr 17;8(2):68. doi: 10.3390/pharmacy8020068.
: Managing patients with a chronic condition such as inflammatory bowel disease (IBD), requires a multidiscipline approach. The pharmacist might be the first point of contact for patients with initial symptoms or relapsing flares, yet there is no available literature on the role of pharmacists in IBD management. We conducted a survey to explore pharmacists' confidence in and potential barriers to managing IBD and assess the impact of IBD education on their confidence in IBD management. : Surveys assessing confidence levels in managing IBD, additional learning opportunities about IBD and barriers to their learning of IBD management were provided to pharmacists for completion before and after attending an IBD-specific education session at a national conference. : Of the 195 attendees, 125 participants completed the survey (64%). Most respondents reported a low to mid-range level of confidence with managing IBD. Specifically, they were only slightly confident in decision making on patient care, addressing patient needs and providing additional support for IBD patients; and somewhat confident with understanding, management and providing relevant information on IBD. Whist the education session improved pharmacists perceived level of confidence, most respondents indicated a need to learn more about IBD. Areas of additional learning included science, drug therapy, treatments (includes non-pharmacological options as well) and guidelines. A majority of pharmacists identified time constraints as a key barrier to learning. : Pharmacists lack sufficient confidence about managing inflammatory bowel disease. These data indicate support within the pharmacy profession to play a more active role in the management of IBD.
管理患有炎症性肠病（IBD）等慢性病的患者需要多学科方法。药剂师可能是出现初始症状或复发发作的患者的首个接触点，但目前尚无关于药剂师在IBD管理中作用的文献。我们进行了一项调查，以探讨药剂师对IBD管理的信心和潜在障碍，并评估IBD教育对他们IBD管理信心的影响。：在全国会议参加特定IBD教育课程之前和之后，向药剂师提供了评估IBD管理信心水平、关于IBD的额外学习机会以及他们学习IBD管理的障碍的调查问卷，以供填写。：在195名与会者中，125名参与者完成了调查（64%）。大多数受访者表示对IBD管理的信心处于中低水平。具体而言，他们在患者护理决策、满足患者需求以及为IBD患者提供额外支持方面仅略有信心；在理解、管理IBD并提供相关信息方面有一定信心。虽然教育课程提高了药剂师的感知信心水平，但大多数受访者表示需要更多地了解IBD。额外学习的领域包括科学、药物治疗、治疗方法（也包括非药物选择）和指南。大多数药剂师认为时间限制是学习的关键障碍。：药剂师对管理炎症性肠病缺乏足够的信心。这些数据表明药学专业内部支持在IBD管理中发挥更积极作用。
